SCHEMBL9253236

SCHEMBL9253236

O/N=C/c1ccc(OCc2csc(-c3ccc(Cl)cc3)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.52
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
GFER P55789 1/20 0.49
MGAM O43451 1/20 0.47
GAA P10253 1/20 0.47
SI P14410 1/20 0.47
MGAM2 Q2M2H8 1/20 0.47
SCN9A Q15858 7/20 0.46
TP53 P04637 3/20 0.46
KCNH2 Q12809 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 2/20 0.45
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
PPARG P37231 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9253242 1.00 ALOX5 (0.52) ALOX5NPC1RAB9AGFERMGAM
SCHEMBL9254559 0.88 RAB9A (0.53) NPC1RAB9ATP53LMNAMAPT
SCHEMBL9254566 0.88 RAB9A (0.53) NPC1RAB9ATP53LMNAMAPT
SCHEMBL9090789 0.88 RAB9A (0.47) ALOX5NPC1RAB9AGAATP53
SCHEMBL9090792 0.88 RAB9A (0.47) ALOX5NPC1RAB9AGAATP53
SCHEMBL9177189 0.87 PPARG (0.53) ALOX5GFERSCN9ATP53KCNH2
SCHEMBL9177195 0.87 PPARG (0.53) ALOX5GFERSCN9ATP53KCNH2
SCHEMBL9262429 0.85 ALOX5 (0.48) ALOX5NPC1RAB9ATP53LMNA
SCHEMBL9262438 0.85 ALOX5 (0.48) ALOX5NPC1RAB9ATP53LMNA
SCHEMBL9263735 0.84 NPC1 (0.54) ALOX5NPC1RAB9AGFERSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5459154-A Enzyme inhibitors as antiinflammatory agents and treatment of atherosclerosis AMERICAN HOME PRODUCTS CORPORATION (US) 1995-10-17 US disclosed